Introduction
The body iron burden is a principal determinant of clinical outcome in all forms of systemic iron overload, whether from transfusion (for thalassemia major, sickle cell disease, aplastic, myelodysplastic, or other refractory anemias), from increased dietary iron absorption (hereditary hemochromatosis and other forms of primary iron overload), or both (refractory anemia with increased ineffective erythropoiesis). Accurate assessment of the body iron is essential for managing iron-chelating therapy in transfused patients to prevent iron toxicity while avoiding the adverse effects of excess chelator administration. In hereditary hemochromatosis, determination of the magnitude of body iron stores permits identification of individuals who would benefit from phlebotomy therapy from among those at genetic risk for the disease .
On April 17, 2001 , an international workshop on the non-invasive measurement of iron was Symptomatic patients may present with any of the characteristic manifestations of systemic iron overload: liver disease with the eventual development of cirrhosis and, often, hepatocellular carcinoma, diabetes mellitus, gonadal insufficiency and other endocrine disorders, arthropathy and increased skin pigmentation; iron-induced cardiomyopathy may be lethal. The prognosis in patients with iron overload is influenced by many factors, including the age at which iron loading begins, the rate and route of iron loading, the distribution of iron deposition between macrophage and parenchymal sites 4 , the amount and duration of exposure to circulating non-transferrin-bound iron 5 ; ascorbate status; and co-existing disorders, especially alcoholism and viral hepatitis. While ferritin and hemosiderin iron are almost surely not the species directly responsible for the adverse effects of iron, the overall magnitude of storage iron accumulation seems to be a principal determinant of clinical outcome in all forms of systemic iron overload.
The reference method for evaluating the extent of body iron excess in systemic iron overload is measurement of the hepatic storage iron concentration 6 , recognizing that the exact relationship in different forms of iron overload, e.g. hereditary hemochromatosis and transfusional iron overload in thalassemia major, sickle cell disease, aplastic and myelodysplastic anemias;
--assessing the value of non-invasive measurements of hepatic iron in guiding (i) ironchelating therapy in transfusional iron overload in patients with thalassemia major, sickle cell disease, aplastic and myelodysplastic anemias and (ii) in identifying patients who would benefit from phlebotomy therapy among those found to be at genetic risk for hereditary hemochromatosis; and --determining the relationships between the iron concentration in specific tissues and damage to the heart, liver, pancreas and other endocrine organs, and joints in different forms of iron overload, e.g., in hereditary hemochromatosis and in transfusional iron overload with thalassemia major, sickle cell disease, aplastic and myelodysplastic anemias.
Physical Properties of Iron:
Iron in biological systems is found with a variety of oxidation states, reduction potentials, magnetic properties, degrees of aggregation, solubilities, mobilities, and kinetic and thermodynamic proclivities towards free radical generation 3, 9 . Each of these variables influences not only the biological activities and toxicities but also the detection and quantification of iron. Reduction-oxidation reactions are involved in the cellular uptake, transmembrane transport and incorporation of iron into essential heme and non-heme enzymes for utilization and into ferritin for storage 10 . Iron is likely to be found in the ferric oxidation state when tightly locked in place for purposes of transport or storage and in the ferrous oxidation state when a change of chemical environment is necessary. Iron can also be a detrimental catalyst in biological free radical oxidations although the exact nature of the reactions involved remain uncertain. Iron-catalyzed free radical production may take place through the Fenton and Haber- coils of wire. Patients are placed in a horizontal cylinder and exposed to the magnetic field. At equilibrium, hydrogen nuclei in the body, which normally have randomly oriented spins, will align in a direction parallel to the magnetic field. The MRI machine then applies short electromagnetic pulses through a coil at a specific radio frequency (RF). The hydrogen nuclei absorb the RF energy and precess away from equilibrium (i.e., alter the orientation of their spins).
When the RF pulse is turned off, the precessing nuclei release the absorbed energy and return to 20 . In the absence of a theoretical understanding of the effects of iron on MRI, empirical efforts to estimate hepatic iron concentrations have used a variety of instruments, magnetic field strengths, imaging sequences (spin-echo, gradient recalled-echo), and parameters (T1 and T2 relaxation times, and signal intensity ratios as measured in proton, T1-, T2-or T2*-weighted images) but no standard or generally accepted method has been adopted for clinical application. To date, MRI has been more useful as a screening technique for the detection of marked iron overload 20 than as a means for quantitative measurement. In particular, with increasing iron concentrations, the signal intensity of the liver is reduced to such an extent that discrimination between different concentrations becomes impossible 21 , at least with current technology.
New methods for using MRI to estimate tissue iron are under development, based on the inverse relationship between the susceptibility-induced relaxation, measured as R2, and iron concentration. One approach, applied in studies of brain iron, involves measuring the tissue relaxation rate (R2) in subjects in both high-and low-field MRI instruments and then calculating the field-dependent R2 increase (FDRI), the difference between the R2 measured with the two MRI instruments. In tissue, only ferritin iron is known to increase R2 in a field-dependent manner, suggesting that the FDRI measure may provide a specific measure of this tissue iron 22, 23 . Another approach also involves measurement of the R2, but uses a spin-echo imaging methodology to produce a series of images at different echo times. Using these images, a "map" of the entire liver is generated in which contrast is predominantly dependent on the R2 of the liver at different echo times 24 . This approach has the advantage that the results are independent of the MRI instrument used. Efforts to validate these approaches against chemical measurements of tissue iron are in progress. In a measurement of hepatic magnetic susceptibility in vivo, the opposing diamagnetic (tissue) and augmenting paramagnetic (ferritin and hemosiderin iron) responses are superimposed. By taking into account the small and nearly constant diamagnetic effect of the liver tissue, the observed resultant magnetic susceptibility may be used, in effect, to count the number of storage iron atoms present.
The contributions of other paramagnetic materials (oxygen, deoxyhemoglobin, some trace metals) to the hepatic magnetic susceptibility are so small that magnetic measurements are highly specific for ferritin and hemosiderin iron. Thus, determinations of the magnetic susceptibility of the liver provide a direct measure of hepatic iron.
To date, measurements of hepatic magnetic susceptibility have required the use of superconducting magnetometers to measure the small change in magnetic field produced by the presence of storage iron in the liver (about one part in a billion of the applied field) 25 .
Superconducting materials lose all electrical resistance below a certain temperature, called the compartments that are in contact by exploiting a resonant frequency discontinuity between the two materials. One material with a known susceptibility (e.g., blood) may then be considered as a reference to obtain the susceptibility of the second material (e.g., liver or heart) 33 . The use of a room-temperature device for susceptibility measurements has been proposed and is being studied 34 . Still another approach is to retain the advantages of superconductivity but to use the new high-high-T C SQUIDs and materials to develop a device that could operate using liquid nitrogen as the refrigerant 35 . Priorities in basic and clinical research in the further development of biomagnetic susceptometry for the measurement of tissue iron were identified as:
--developing innovative instrumentation for biomagnetic susceptometry that is suitable for routine clinical use in studies of iron overload, such as liquid-nitrogen cooled superconducting instruments, devices using non-superconducting magnetometers, or means of adapting magnetic resonance imaging instruments for measurement of magnetic susceptibility;
--improving biomagnetic susceptometry by the development of methods to more precisely determine the susceptibility of tissue overlying the organ of interest, as for example, the bone, muscle and subcutaneous tissue overlying the liver.
--Additional research is needed to develop biomagnetic susceptometry as a means of measuring tissue iron concentrations in the heart, endocrine tissue, brain and other organs, by the use of instrumentation with arrays of magnetic sensors or by examining the potential use of magnetic susceptibility tomography 25 . 
Summary and Recommendations

